Consequences of Prohibition
Drug War Issues
Politics & Advocacy
Trump once again proposes radically slashing the drug czar's office, senators want answers on federal drug policy appointments (and the lack thereof), Vermont's governor will sign the legal pot bill this weekend, and more.
From marijuana to the opioid crisis, drug policy is getting attention in Congress these days. (Wikimedia)
House Budget Amendment to Protect State-Legal Marijuana Dies. Rep. Jared Polis (D-CO), coauthor of the McClintock-Polis amendment protecting state-legal marijuana programs, has pulled the amendment from the continuing budget resolution, citing lack of support from the Republican leadership. The amendment would have protected both medical marijuana and adult use marijuana by barring the use of Justice Department funds to go after them.
Trump Administration Reviewing Guidance for Banks Dealing With Legal Marijuana. A top Treasury Department official told Congress Wednesday that the administration is reviewing whether to keep Obama-era guidance providing a route for banks to serve marijuana businesses without getting in trouble with federal regulators. "We are reviewing the guidance in light of the attorney general's recent decision to revoke a Justice Department memorandum on this issue, Sigal Mandelker, the department's deputy secretary, said at a Senate hearing in remarks reported by Marijuana Moment.
Vermont Governor Will Sign Legalization Bill This Weekend. Gov. Phil Scott (R) said Thursday he will sign the marijuana legalization bill, House Bill 511, sometime this weekend. The bill legalizes the possession and cultivation of small amounts of marijuana, but not commercial activity. Scott said he will sign the bill without ceremony out of respect for those who oppose the measure. Once he does, Vermont will become the first state to have legalized marijuana through the state legislature.
Medical Marijuana
Utah Congressman Files Federal Medical Marijuana Research Bill. Rep. Rob Bishop (R-UT) filed a House version of a bill aiming at encouraging medical marijuana research on Thursday. Utah Sen. Orrin Hatch (R) filed the Senate version of the Marijuana Effective Drug Study Act, Senate Bill 1803, in the Senate in September.
Pennsylvania's First Dispensary Opens for Business. Keystone Canna Remedies had its grand opening in Bethlehem on Wednesday -- but it doesn't actually have any product to sell. The dispensary said it will be doing educational workshops until it gets its first shipments of medical marijuana next month.
Tennessee CBD Medical Marijuana Bill Filed. A pair of Republican lawmakers have filed the Medical Cannabis Only Act, which would legalize the use of cannabis oil products, but not edibles or raw marijuana. The bill is not yet available on the legislative website.
Drug Policy
Trump Administration Again Plans Deep Cuts to Drug Czar's Office. The administration is once again planning to slash the budget of the Office of National Drug Control Policy (ONDCP -- the drug czar's office). According to a report in Politico, the plan is to shift ONDCP's two main grant programs, the High Intensity Drug Trafficking Areas grants and the Drug Free Communities grants to the departments of Justice and Health and Human Services, respectively. That would shift ONDCP's budget by about $340 million, or 95%. The move comes as the nation confronts a severe opioid crisis, lending fuel to claims the Trump administration isn't doing enough on the issue.
Senators Call on Trump Administration to Explain Drug Policy Appointments. Driven by revelations that a 24-year-old former campaign worker is playing a key role in the Office of National Drug Control Policy (ONDCP -- the drug czar's office), as well as the administration's failure to fill key drug policy positions, a group of senators sent a letter Thursday calling on the administration to provide information on all political appointees serving in drug policy positions. The letter also called on the administration to identify, nominate, and confirm qualified leaders for the drug czar's office and the DEA. "You have claimed that that the opioid epidemic is a top priority for your administration, but the personnel you have staffing these key agencies -- and the lack of nominees to head them -- is cause for deep concern," the letter said. "This crisis knows no bounds, and we are committed to working across party lines with anyone who is serious about addressing this devastating epidemic."
Permission to Reprint: This content is licensed under a modified Creative Commons Attribution license. Content of a purely educational nature in Drug War Chronicle appear courtesy of DRCNet Foundation, unless otherwise noted.
Add new comment